Taiwan Otsuka Pharm. Co., Ltd clinical trials
A country office of Otsuka Holdings Co., Ltd.
The registry lists 7 studies whose lead sponsor is Taiwan Otsuka Pharm. Co., Ltd. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 2, 2015.
Registry sponsor names on this page
- Taiwan Otsuka Pharm. Co., Ltd7 studies
Something wrong with this grouping? Tell us on the Otsuka Holdings Co., Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 7 of 7. All Otsuka Holdings Co., Ltd. studies →
- Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart FailureCompletedNCT01618448Phase 3
Sponsor listed in the registry: Taiwan Otsuka Pharm. Co., Ltd
- Aripiprazole for the Augmentation of Antidepressant TherapyCompletedNCT01429831Phase 4
Sponsor listed in the registry: Taiwan Otsuka Pharm. Co., Ltd
- A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler and Berotec N® Metered Aerosol in Mild to Moderate Stable Asthma PatientsCompletedNCT01095016Phase 3
Sponsor listed in the registry: Taiwan Otsuka Pharm. Co., Ltd
- A Study to Evaluate Efficacy and Safety Effects Using Mikelan® LA Ophthalmic Solution (OS) 2% Versus Timoptol® XE Ophthalmic Solution (OS) 0.5% in Ocular Hypertension PatientsCompletedNCT00972426Phase 4
Sponsor listed in the registry: Taiwan Otsuka Pharm. Co., Ltd
- A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler® and Ventolin® MDI in Stable Asthma PatientsCompletedNCT01076322Phase 3
Sponsor listed in the registry: Taiwan Otsuka Pharm. Co., Ltd
- Health Evaluation of Abilify Long-term TherapyCompletedNCT00520650Phase 4
Sponsor listed in the registry: Taiwan Otsuka Pharm. Co., Ltd
- Aripiprazole in the Treatment of Acutely Relapsed Patients With SchizophreniaCompletedNCT00283179Phase 3
Sponsor listed in the registry: Taiwan Otsuka Pharm. Co., Ltd